Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000015375
- Lead Sponsor
- Severance Hospital, Yonsei University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients with previous H. pylori eradication therapy; (2) patients treated with H2 receptor antagonist, PPI, and antibiotics in the previous 4 weeks, or nonsteroidal anti-inflammatory drug (NSAID) in the previous 2 weeks; (3) pregnant or lactating women; (4) patients who suffered from serious diseases such as severe liver disease, renal disease, and cerebrovascular disease; (5) patients who had a drug allergy to the study drugs; and (6) patients with previous gastric surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate of H pylori infection
- Secondary Outcome Measures
Name Time Method Drug adherence and the frequency of adverse events